Latest Breaking News On - உலகளாவிய சுகாதாரம் வாய்ப்புகள் - Page 1 : comparemela.com
Durham clinical trial startup Velocity adds new execs for European expansion
wraltechwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wraltechwire.com Daily Mail and Mail on Sunday newspapers.
GHO Capital Announces Final Close of Fund III With Over €2 Billion of Capital to Invest
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Harris Williams Advises Velocity Clinical Research on its Sale to GHO Capital Partners LLP
May 3, 2021 GMT
RICHMOND, Va. (BUSINESS WIRE) May 3, 2021
Harris Williams, a global investment bank specializing in M&A advisory services, announces it advised Velocity Clinical Research (Velocity), a portfolio company of NaviMed Capital (NaviMed), on its sale to Global Healthcare Opportunities, or GHO Capital Partners LLP (GHO). Velocity is a leading integrated site organization for clinical trials. The transaction was led by Paul Hepper, Nick Owens, Lucas Scholl, Katie Bowden and Jonathan Ferrell of the Harris Williams Healthcare & Life Sciences (HCLS) Group.
Harris Williams Advises Velocity Clinical Research on its Sale to GHO Capital Partners LLP
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Velocity Clinical Research acquired by GHO signalling evolution of clinical trial site industry
News provided by
Share this article
Share this article
DURHAM, N.C., April 8, 2021 /PRNewswire/ Leading integrated clinical trial site organisation, Velocity Clinical Research ( Velocity ), today announces it has entered into an agreement with Global Healthcare Opportunities, or GHO Capital ( GHO ), the European specialist investor in healthcare, to be acquired from NaviMed Capital ( NaviMed ) and other investors, signalling how the business of running clinical trial sites is changing.
Headquartered in Durham, North Carolina, Velocity operates 16 fully-owned sites across 11 US states. The company serves biopharmaceutical and contract research organisation (CRO) clients in primarily conducting phase II and phase III clinical trials in support of their global drug development programs. In just three years, Velocity has worked with over 200 biopharmaceutical clients, including all of